NYSE:CO

Global Cord Blood - CO Stock Forecast, Price & News

$2.67

+0.08 (+3.09%)

(As of 08/12/2022 12:00 AM ET)

Add

Compare

Today's Range: $2.55
▼
$2.67
50-Day Range: $2.05
▼
$3.49
52-Week Range: $2.03
▼
$5.50

Volume: 186,832 shs
Average Volume: 166,788 shs
Market Capitalization: $324.54 million

P/E Ratio: 4.17
Dividend Yield: N/A
Price Target: N/A

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Global Cord Blood in a report on Friday, June 3rd. They issued a "strong-buy" rating for the company.

Global Cord Blood Trading Up 1.2 %

Shares of Global Cord Blood stock traded up $0.03 during trading hours on Friday, reaching $2.62. 75 shares of the company's stock were exchanged, compared to its average volume of 121,939. The firm has a market capitalization of $318.46 million, a price-to-earnings ratio of 4.05 and a beta of 0.14. The company has a fifty day moving average of $2.80 and a 200-day moving average of $3.33. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50.

Global Cord Blood (NYSE:CO - Get Rating) last issued its earnings results on Tuesday, July 5th. The medical research company reported $0.14 earnings per share (EPS) for the quarter. Global Cord Blood had a net margin of 40.29% and a return on equity of 10.63%. The firm had revenue of $46.88 million for the quarter.

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Stock News Headlines

August 11, 2022 | finance.yahoo.com

Cord Blood Banking Services Market to Rise at CAGR of 10.9% during Forecast Period, notes TMR Study

August 9, 2022 | benzinga.com

Global Natural Killer (NK) Cell Therapeutics Markets, 2022-2032 - Increasing Funding and Investment & Rising Number of Partnerships and Collaborations

August 8, 2022 | marketwatch.com

Global Blood and Organ Bank Market Size and Growth New Project SWOT Analysis, Market Share, Investment Feasibility Analysis and Forecast to 2028

July 29, 2022 | americanbankingnews.com

Reviewing Global Cord Blood (NYSE:CO) & Marpai (NASDAQ:MRAI)

July 25, 2022 | nz.finance.yahoo.com

Biobanking Market size is projected to reach USD 69.51 billion by 2030, growing at a CAGR of 6.2%: Straits Research

July 22, 2022 | nz.finance.yahoo.com

Global Cryopreservation Equipment Market to Reach $12.48 Billion by 2028 at a CAGR of 11.9%

July 21, 2022 | tmcnet.com

Cryopreservation Equipment Market Report 2022-2028: Growing Acceptance

July 21, 2022 | marketwatch.com

Cord Blood Banking Service Market Size: Projected to reach USD 84610 million with Top Companies, Share Analysis, Future Growth, and Forecast to 2028

July 21, 2022 | marketwatch.com

Cord Blood Banking Services Market Size 2022: 3.6% CAGR | Latest Trend, Share, Growth, Competitors and Forecast

July 14, 2022 | nasdaq.com

Thursday Sector Leaders: Semiconductors, Diagnostics

July 12, 2022 | marketwatch.com

Global Cord Blood Banking Services Market Size 2022, Recent Trends, Demand and Share Estimation by 2029 with Top Players

July 6, 2022 | finance.yahoo.com

Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

July 5, 2022 | finance.yahoo.com

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

July 5, 2022 | finance.yahoo.com

Biobanking Market Size Worth USD 2.69 billion by 2030: Exclusive Report by Growth Plus Reports

June 28, 2022 | uk.finance.yahoo.com

Does the Global Cord Blood share price make it a stock for contrarians?

June 17, 2022 | marketwatch.com

Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND

June 16, 2022 | markets.businessinsider.com

Global Cord Blood Stock Gains As FDA Announced Clearance To Study Blood Cancer Candidate

June 16, 2022 | finance.yahoo.com

Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation

June 16, 2022 | finance.yahoo.com

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

June 16, 2022 | finance.yahoo.com

Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened

June 15, 2022 | finance.yahoo.com

Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights

June 8, 2022 | marketwatch.com

Cord Blood Banking Market Size In 2022 with Top Countries Data : What is the growth rate of the Industry? | In-Depth Analysis with 107 Report Pages

June 3, 2022 | seekingalpha.com

Global Cord up over 20% as investors seek meeting to oppose Cellenkos acquisition

June 3, 2022 | finance.yahoo.com

Shareholders Led by Blue Ocean Call Extraordinary General Meeting of Global Cord Blood Corporation Shareholders to Terminate its Proposed Acquisition of Cellenkos, Inc. and Elect New Board

May 27, 2022 | finance.yahoo.com

Blue Ocean Announces Virgin Islands Court Grants Injunction Order Prohibiting Golden Meditech from Taking Any Steps on a Purported Share Charge from Blue Ocean or Pursuing the Removal of Blue Ocean’s Representative as a Director of Global Cord Blood

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings: 7/05/2022
Today: 8/12/2022
Next Earnings (Estimated): 8/29/2022
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:CO
CUSIP: N/A
CIK: 1467808
Web: www.globalcordbloodcorp.com
Phone: (523) 605-8180
Fax: 852-3605-8181
Employees: 1,260
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.64
Trailing P/E Ratio: 4.17
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $79.04 million
Net Margins: 40.29%
Pretax Margin: 50.50%
Return on Equity: 10.63%
Return on Assets: 6.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 10.73
Quick Ratio: 10.66

Sales & Book Value

Annual Sales: $196.12 million
Price / Sales: 1.65
Cash Flow: $0.71 per share
Price / Cash Flow: 3.74
Book Value: $6.34 per share
Price / Book: 0.42

Miscellaneous

Outstanding Shares: 121,551,000
Free Float: N/A
Market Cap: $324.54 million
Optionable: Optionable
Beta: 0.14

Key Executives

Ms. Ting Zheng (Age 50)
CEO & CEO of Beijing Division
Comp: $516.68k
Mr. Bing Chuen Chen (Age 46)
Chief Financial Officer
Comp: $516.68k
Ms. Xin Xu (Age 68)
Chief Technology Officer
Comp: $122.78k
Ms. Rui Arashiyama (Age 63)
Chief Exec. Officer of Guangdong & Zhejiang Divisions
Comp: $257.5k
Ms. Cathy Bai
VP of Corp. Fin.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CO Stock - Frequently Asked Questions

How have CO shares performed in 2022?: Global Cord Blood's stock was trading at $4.19 on January 1st, 2022. Since then, CO shares have decreased by 36.3% and is now trading at $2.67.
View the best growth stocks for 2022 here.
Are investors shorting Global Cord Blood?: Global Cord Blood saw a decline in short interest in July. As of July 31st, there was short interest totaling 197,600 shares, a decline of 13.0% from the July 15th total of 227,000 shares. Based on an average daily trading volume, of 170,600 shares, the days-to-cover ratio is presently 1.2 days. Approximately 0.6% of the shares of the stock are short sold.
View Global Cord Blood's Short Interest.
When is Global Cord Blood's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, August 29th 2022.
View our CO earnings forecast.
How were Global Cord Blood's earnings last quarter?: Global Cord Blood Co. (NYSE:CO) released its earnings results on Tuesday, July, 5th. The medical research company reported $0.14 EPS for the quarter. The medical research company had revenue of $46.88 million for the quarter. Global Cord Blood had a net margin of 40.29% and a trailing twelve-month return on equity of 10.63%.
What other stocks do shareholders of Global Cord Blood own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?: Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."
Who are Global Cord Blood's major shareholders?: Global Cord Blood's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Group One Trading L.P. (0.00%).
View institutional ownership trends.
How do I buy shares of Global Cord Blood?: Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Global Cord Blood's stock price today?: One share of CO stock can currently be purchased for approximately $2.67.
How much money does Global Cord Blood make?: Global Cord Blood (NYSE:CO) has a market capitalization of $324.54 million and generates $196.12 million in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis.
How many employees does Global Cord Blood have?: The company employs 1,260 workers across the globe.
How can I contact Global Cord Blood?: Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 8/12/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Global Cord Blood - CO Stock Forecast, Price & News

About Global Cord Blood (NYSE:CO) Stock

Analyst Ratings Changes

Global Cord Blood Trading Up 1.2 %

CO Stock News Headlines

CO Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CO Stock - Frequently Asked Questions

How have CO shares performed in 2022?

Are investors shorting Global Cord Blood?

When is Global Cord Blood's next earnings date?

How were Global Cord Blood's earnings last quarter?

What other stocks do shareholders of Global Cord Blood own?

What is Global Cord Blood's stock symbol?

Who are Global Cord Blood's major shareholders?

How do I buy shares of Global Cord Blood?

What is Global Cord Blood's stock price today?

How much money does Global Cord Blood make?

How many employees does Global Cord Blood have?

How can I contact Global Cord Blood?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources